Pharmacoproteomics:: Advancing the efficacy and safety of regenerative therapeutics

被引：23

作者：

Arrell, D. K.

Niederlaender, N. J.

Perez-Terzic, C.

Chung, S.

Behfar, A.

Terzic, A. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Marriott Heart Dis Res Program,Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Marriott Heart Dis Res Program,Dept Mol Pharmacol, Div Cardiovasc Dis, Rochester, MN USA

[3] Mayo Clin, Coll Med, Marriott Heart Dis Res Program,Dept Med Genet, Div Cardiovasc Dis, Rochester, MN USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 03期

关键词：

D O I：

10.1038/sj.clpt.6100310

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Proteomic analyses encompass a suite of high-throughput technologies for large- scale separation and identification of proteins responsible for execution of physiological processes. As such, proteomics is ideally suited to dissecting developmental complexity and dynamics, an understanding of which is vital to the realization of regenerative therapeutic medicine. Pharmacoproteomics is increasingly targeting characterization of regenerative therapeutic strategies. A perspective on the application of proteomics to further our understanding of cardiac regenerative medicine, in concert with guided cardiogenic programming, is delineated herein.

引用

页码：316 / 319

页数：4

共 13 条

[1] ARRELL DK, 2006, ADV MOL MED, V2, P149
[2] Stem cell differentiation requires a paracrine pathway in the heart
Behfar, A
Zingman, LV
Hodgson, DM
Rauzier, JM
Kane, GC
Terzic, A
Pucéat, M
[J]. FASEB JOURNAL, 2002, 16 (12) : 1558 - 1566
[3] Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair
Behfar, A
Hodgson, DM
Zingman, LV
Perez-Terzic, C
Yamada, S
Kane, GC
Alekseev, AE
Pucéat, M
Terzic, A
[J]. STEM CELL BIOLOGY: DEVELOPMENT AND PLASTICITY, 2005, 1049 : 189 - 198
[4] Stable benefit of embryonic stem cell therapy in myocardial infarction
Hodgson, DM
Behfar, A
Zingman, LV
Kane, GC
Perez-Terzic, C
Alekseev, AE
Pucéat, M
Terzic, A
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (02): : H471 - H479
[5] Electromechanical integration of cardiomyocytes derived from human embryonic stem cells
Kehat, I
Khimovich, L
Caspi, O
Gepstein, A
Shofti, R
Arbel, G
Huber, I
Satin, J
Itskovitz-Eldor, J
Gepstein, L
[J]. NATURE BIOTECHNOLOGY, 2004, 22 (10) : 1282 - 1289
[6] Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium
Kolossov, Eugen
Bostani, Toktam
Roell, Wilhelm
Breitbach, Martin
Pillekamp, Frank
Nygren, Jens M.
Sasse, Philipp
Rubenchik, Olga
Fries, Jochen W. U.
Wenzel, Daniela
Geisen, Caroline
Xia, Ying
Lu, Zhongju
Duan, Yaqi
Kettenhofen, Ralf
Jovinge, Stefan
Bloch, Wilhelm
Bohlen, Heribert
Welz, Armin
Hescheler, Juergen
Jacobsen, Sten Eirik
Fleischmann, Bernd K.
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) : 2315 - 2327
[7] Regenerating the heart
Laflamme, MA
Murry, CE
[J]. NATURE BIOTECHNOLOGY, 2005, 23 (07) : 845 - 856
[8] Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium:: a preclinical study
Ménard, C
Hagège, AA
Agbulut, O
Barro, M
Morichetti, MC
Brasselet, C
Bel, A
Messas, E
Bissery, A
Bruneval, P
Desnos, M
Pucéat, M
Menasché, P
[J]. LANCET, 2005, 366 (9490) : 1005 - 1012
[9] Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells
Nelson, Timothy J.
Ge, Zhi-Dong
Van Orman, Jordan
Barron, Matthew
Rudy-Reil, Diane
Hacker, Timothy A.
Misra, Ravi
Duncan, Stephen A.
Auchampach, John A.
Lough, John W.
[J]. ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2006, 288A (11): : 1216 - 1224
[10] Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery
Perez-Terzic C.
Faustino R.S.
Boorsma B.J.
Arrell D.K.
Niederländer N.J.
Behfar A.
Terzic A.
[J]. Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (Suppl 1): : S68 - S76

← 1 2 →